ArticleTheranostics2017

Concurrent Chemoradiotherapy with or without Anti-EGFR-Targeted Treatment for Stage II-IVb Nasopharyngeal Carcinoma: Retrospective Analysis with a Large Cohort and Long Follow-up.

Rui You et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.